Brief: Pieris Pharmaceuticals Inc Posts Qtrly Loss Per Share 25 Cents
Aug 4 (Reuters) - Pieris Pharmaceuticals Inc PIRS.O :
* PIERIS PHARMACEUTICALS INC QTRLY LOSS PER SHARE 25 CENTS;
QTRLY
REVENUE $3.3 MILLION VERSUS $11.2 MILLION
Further company coverage: PIRS.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Palvella Therapeutics
See all newsPalvella Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Palvella Therapeutics Q2 net loss widens on higher expenses
Brief: Palvella Therapeutics Announces New Data From The Phase 2 Toiva Trial Of Qtorin™ Rapamycin In Cutaneous Venous Malformations
Brief: Palvella Therapeutics Announces Uplisting To The Nasdaq Global Market
Palvella Therapeutics' Q1 net loss widens on higher costs